A Study of LY3200327 in Healthy Participants
NCT02595736
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Placebo (SC)
DRUG:
LY3200327 (SC)
DRUG:
LY3200327 (IV)
DRUG:
Placebo (IV)
Sponsor
Eli Lilly and Company